Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|36|4|205-215

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.36, Iss.4, 2015-05, pp. : 205-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pirfenidone: a guide to its use in idiopathic pulmonary fibrosis

By Keating Gillian M.   Lyseng-Williamson Katherine A.   Carter Natalie J.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 7, 2012-07 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

By Antoniu Sabina A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1443-1447

Informa Healthcare

Access to resources Recommend Favorite

The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy

By Gharaee-Kermani Mehrnaz   Hu Biao   Phan Sem H   Gyetko Margaret R  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 905-916

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 14, 2016-06 ,pp. : 1587-1598

Bentham Science Publishers

Access to resources Recommend Favorite